Prophylactic and therapeutic monoclonal antibodies
US6451309B2 · kind B2 · utility
14Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2001 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Feb 9, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In this application are described vaccinia monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of vaccinia virus infections in vitro and in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.